NCT03239145 2026-03-12
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Phase 1 Completed
Clinical Trials
250 trialsNCT03519412 2026-03-03
ARETHUSA
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2 Completed
NCT03828799 2026-02-27
FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1/2 Completed
NCT01105169 2026-02-20
Precision-Based Magnesium Trial
Vanderbilt University Medical Center
Phase NA Completed
NCT02738606 2026-02-17
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT05383976 2026-02-11
PCSNaP
Abramson Cancer Center at Penn Medicine
Completed
NCT04414306 2026-02-02
Screen to Save 2: Rural Cancer Screening Educational Intervention
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT05746195 2026-01-22
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
Phase NA Completed
NCT04457297 2026-01-21
ALTAIR
National Cancer Center Hospital East
Phase 3 Completed
NCT04514341 2026-01-14
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
Completed
NCT04763824 2026-01-14
KANSURVIVE
University of Kansas Medical Center
Phase NA Completed
NCT03983993 2026-01-05
NIPAVect
Emory University
Phase 2 Active not recruiting
NCT06016725 2026-01-02
E-PROOF
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
NCT04905082 2025-12-11
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Phase NA Active not recruiting
NCT06331403 2025-11-24
Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors
Massachusetts General Hospital
Phase NA Completed
NCT03829462 2025-11-21
NEXT-REGIRI
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3 Active not recruiting
NCT04336397 2025-11-19
Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People
Alaska Native Tribal Health Consortium
Phase NA Completed
NCT01312857 2025-10-09
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04526886 2025-10-06
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT04259762 2025-09-24
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance
Phase NA Completed
NCT05678257 2025-09-12
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
NuCana plc
Phase 2 Terminated
NCT02870049 2025-09-04
Study to Increase Colorectal Screening
University of California, San Diego
Phase NA Completed
NCT05686122 2025-09-04
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings (PainPac)
Duke University
Phase NA Completed
NCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
NCT06436300 2025-08-29
Colorectal Cancer Screening in Alaska Native Men
Washington State University
Phase NA Completed
NCT05980182 2025-08-20
SUCCEED
Virginia Commonwealth University
Phase NA Completed
NCT06185374 2025-08-20
Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital
NYU Langone Health
Phase NA Completed
NCT04890054 2025-08-19
SMARTER CRC
OHSU Knight Cancer Institute
Phase NA Completed
NCT06048367 2025-08-03
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
Phase 1 Completed
NCT02821793 2025-07-01
PRIORITY
Institut Bergonié
Completed
NCT03630354 2025-07-01
EXERCISING TOGETHER for Couples Coping With Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT04786600 2025-07-01
A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial
University of Florida
Phase 2 Terminated
NCT04500171 2025-06-24
Colorectal Cancer Screening Assessment Study
University of Hawaii
Phase NA Completed
NCT02368886 2025-06-18
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Academic and Community Cancer Research United
Phase 2 Completed
NCT03642067 2025-06-15
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00574353 2025-05-09
Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01550510 2025-05-06
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Phase 1/2 Terminated
NCT04853043 2025-05-06
APK Mutant
University of Utah
Phase 2 Terminated
NCT02272244 2025-05-04
Increasing Colorectal Cancer (CRC) Screening Among Hispanic Primary Care Patients
Thomas Jefferson University
Phase NA Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT03428958 2025-04-23
A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment
NuCana plc
Phase 1/2 Completed
NCT04705363 2025-04-18
A Sociolinguistic-enabled Web Application to Develop Precision Health Intervention for African Americans
University of Florida
Phase NA Completed
NCT03610490 2025-04-17
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02895464 2025-03-25
Feasibility of Home-based Preoperative Exercise in Older People
Karolinska Institutet
Phase NA Completed
NCT05061017 2025-03-07
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)
University of Pittsburgh
Phase 2 Completed
NCT03396926 2025-02-28
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
University of California, San Francisco
Phase 2 Completed
NCT00961571 2025-02-12
Sunitinib and Capecitabine for First Line Colon Cancer
Georgetown University
Phase 2 Terminated
NCT01652196 2025-02-05
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT04492007 2025-02-03
PRISMS
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed